Anixa Biosciences Inc (ANIX)
NASDAQ:ANIX
Holding ANIX?
Track your performance easily

Anixa Biosciences (ANIX) Financial Statements

393 Followers

Anixa Biosciences Financial Overview

Anixa Biosciences's market cap is currently ―. The company's EPS TTM is $-0.39; its P/E ratio is -8.81; Anixa Biosciences is scheduled to report earnings on March 8, 2024, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.
Jul 24Apr 24Jan 24Oct 23Jul 23
Income Statement-
Total Revenue-----
Gross Profit--$ -3.61M$ 5.40M$ -2.84M
EBIT$ -3.31M$ -3.14M$ -3.61M$ -2.72M$ -2.55M
EBITDA$ -3.31M$ -3.13M$ -3.60M$ -2.71M$ -2.54M
Net Income Common Stockholders$ -3.28M$ -3.14M$ -3.25M$ -2.69M$ -2.51M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 20.75M$ 23.24M$ 23.80M$ 23.84M$ 25.53M
Total Assets$ 22.91M$ 24.36M$ 25.37M$ 25.52M$ 26.58M
Total Debt$ 237.00K$ 149.00K$ 162.00K$ 175.00K$ 187.00K
Net Debt$ -20.51M$ -23.09M$ -23.64M$ -23.67M$ -25.35M
Total Liabilities$ 2.22M$ 1.77M$ 1.77M$ 2.15M$ 1.99M
Stockholders Equity$ 21.77M$ 23.62M$ 24.61M$ 24.34M$ 25.52M
Cash Flow-
Free Cash Flow$ -2.64M$ -1.46M$ -2.31M$ -1.97M$ -1.45M
Operating Cash Flow$ -2.64M$ -1.46M$ -2.31M$ -1.97M$ -1.45M
Investing Cash Flow$ 2.72M$ 556.00K$ 129.00K$ -593.00K$ -980.00K
Financing Cash Flow$ 149.00K$ 897.00K$ 2.26M$ 279.00K$ 3.00K
Currency in USD

Anixa Biosciences Earnings and Revenue History

Anixa Biosciences Debt to Assets

Anixa Biosciences Cash Flow

Anixa Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis